Research Notes

Disease and Telomerase Telomerase, the ribonucleoprotein, uses part of itself as a template to tack six-base repeats onto the tips of chromosomes in cells of highly proliferative tissues. Compromised telomerase, then, is likely to affect tissues with high turnover rates. University of California, Berkeley, researchers recently tightened that link (J.R. Mitchell et al., "A telomerase component is defective in the human disease dyskeratosis congenita," Nature, 402:551-5, Dec. 2, 1999). Dyskeratosi

Written byRicki Lewis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Disease and Telomerase

Telomerase, the ribonucleoprotein, uses part of itself as a template to tack six-base repeats onto the tips of chromosomes in cells of highly proliferative tissues. Compromised telomerase, then, is likely to affect tissues with high turnover rates. University of California, Berkeley, researchers recently tightened that link (J.R. Mitchell et al., "A telomerase component is defective in the human disease dyskeratosis congenita," Nature, 402:551-5, Dec. 2, 1999). Dyskeratosis congenita, which is passed from carrier mothers to affected sons, affects rapidly dividing epithelium and bone marrow, causing numerous ailments. The disease was identified in 1964, and the molecular defect, in a protein called dyskerin, was discovered in 1998. Dyskerin interacts with telomerase. The researchers found that patients' cells have less telomerase RNA, lower telomerase activity, and shorter telomeres, which causes the chromosomal instability that predisposes to cancer. "If telomeres get too short and the cell escapes proliferative senescence or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies